Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) |
Stages | Seed, Startup, Early Stage |
Investing | United States |
Investment Range | $500,000 - $2,000,000 |
Assets Under Management | $25,000,000 |
Apjohn Ventures Fund, LP is a venture capital firm operating out of Kalamazoo, Michigan, with a focus on investing in early-stage companies within the life sciences sector. They primarily target businesses across the Midwest region. The fund sets out with the investment thesis to provide investors with superior financial returns by making equity investments in innovative life sciences companies, characterized by sustainable and outstanding growth potential. Their specialty lies in seed, startup, and early-stage investments, considering amounts ranging from a minimum of $500,000 to a maximum of $2,000,000 equity commitment. With assets under management totaling $25,000,000, Apjohn Ventures actively seeks opportunities to fund forward-thinking Biotech, HealthTech, Fitness, and Medical Devices & Hospital Services industries. The venture firm prides itself on its deep expertise in equity funding, aiming to inspire and enable entrepreneurs to build successful enterprises in the life sciences arena, much like Dr. William E. Upjohn's historical pharmaceutical achievements. Apjohn Ventures carries the original family name of one of the founders, symbolizing a bridge between a legacy of innovation and modern entrepreneurial ventures. At their core, the fund values its connection to the region, having been established to harness the potential of the Midwest's burgeoning life sciences ecosystem, and endeavours to continue contributing to its growth and success.